Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kelly Maloney

Concepts (374)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
296
5.550
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
2025
89
1.630
Why?
Antineoplastic Combined Chemotherapy Protocols
18
2026
1958
1.230
Why?
Down Syndrome
6
2023
525
1.220
Why?
Burkitt Lymphoma
3
2024
61
0.920
Why?
Leukemia, Myeloid, Acute
7
2026
686
0.870
Why?
Asparaginase
8
2020
30
0.830
Why?
Fishes
1
2024
109
0.800
Why?
Agriculture
1
2024
93
0.790
Why?
Child
74
2026
22670
0.730
Why?
Bayes Theorem
1
2024
419
0.720
Why?
Consolidation Chemotherapy
2
2019
11
0.650
Why?
Ecosystem
1
2024
478
0.610
Why?
Neoplasm Recurrence, Local
6
2025
1146
0.610
Why?
Child, Preschool
49
2026
11835
0.600
Why?
Disease-Free Survival
12
2024
766
0.540
Why?
Leukemia
4
2021
246
0.530
Why?
Oncogene Proteins, Fusion
6
2024
212
0.530
Why?
Mercaptopurine
5
2017
15
0.500
Why?
Prognosis
17
2026
4310
0.500
Why?
Infant
36
2026
10060
0.450
Why?
Antineoplastic Agents
7
2019
2207
0.450
Why?
Recurrence
12
2025
1134
0.450
Why?
Preleukemia
1
2015
2
0.440
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
127
0.440
Why?
Drug Hypersensitivity
3
2017
90
0.430
Why?
Molecular Targeted Therapy
3
2021
438
0.420
Why?
Leukemia, Monocytic, Acute
1
2014
3
0.420
Why?
Sarcoma, Myeloid
1
2014
4
0.420
Why?
Neoplasm, Residual
7
2023
143
0.400
Why?
Adolescent
42
2026
22479
0.390
Why?
Bone Marrow Transplantation
1
2014
297
0.370
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
26
0.360
Why?
Erwinia
2
2020
3
0.350
Why?
Medical Oncology
5
2025
338
0.350
Why?
Tumor Suppressor Proteins
3
1999
320
0.350
Why?
Humans
86
2026
145140
0.350
Why?
Chromosome Aberrations
2
2022
165
0.340
Why?
Acute Kidney Injury
1
2019
872
0.340
Why?
Neutropenia
2
2022
154
0.330
Why?
Male
58
2026
72664
0.330
Why?
Stem Cell Transplantation
3
2019
189
0.320
Why?
Hematopoietic Stem Cell Transplantation
2
2019
698
0.320
Why?
Rhabdomyosarcoma
1
2011
64
0.320
Why?
Cell Cycle Proteins
3
1999
629
0.310
Why?
Carrier Proteins
3
1999
728
0.310
Why?
Sarcoma, Ewing
1
2011
103
0.300
Why?
Biomarkers, Tumor
3
2026
1320
0.300
Why?
Ploidies
2
2019
20
0.300
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
193
0.290
Why?
Core Binding Factor Alpha 2 Subunit
3
2021
30
0.280
Why?
Genes, Tumor Suppressor
2
1999
85
0.280
Why?
Catheter-Related Infections
2
2022
96
0.280
Why?
Survival Rate
8
2024
2087
0.280
Why?
Cyclophosphamide
4
2019
266
0.280
Why?
Female
56
2026
78636
0.270
Why?
Catheterization, Central Venous
2
2022
123
0.260
Why?
Philadelphia Chromosome
2
2018
18
0.260
Why?
Medication Adherence
3
2017
540
0.250
Why?
Gene Deletion
2
1998
391
0.240
Why?
Vincristine
4
2021
140
0.230
Why?
Neoplasm Proteins
2
2018
441
0.230
Why?
Trisomy
2
2021
78
0.230
Why?
Antimetabolites, Antineoplastic
2
2017
105
0.230
Why?
Etoposide
2
2019
167
0.230
Why?
Ikaros Transcription Factor
1
2025
23
0.220
Why?
Young Adult
15
2024
14176
0.210
Why?
Maryland
1
2024
67
0.210
Why?
Invertebrates
1
2024
21
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
72
0.210
Why?
Rivers
1
2024
62
0.200
Why?
Treatment Outcome
12
2023
11741
0.200
Why?
PAX5 Transcription Factor
2
2024
14
0.200
Why?
Anxiety
3
2016
1117
0.200
Why?
Polymorphism, Single Nucleotide
4
2025
2136
0.190
Why?
Genomics
4
2025
819
0.190
Why?
Gene Rearrangement
3
2019
155
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
76
0.180
Why?
Polyethylene Glycols
5
2020
649
0.180
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
4
0.180
Why?
Induction Chemotherapy
2
2019
87
0.180
Why?
Environmental Monitoring
1
2024
346
0.170
Why?
Central Venous Catheters
1
2022
53
0.170
Why?
Health Equity
1
2024
133
0.170
Why?
Program Evaluation
2
2017
943
0.170
Why?
Prednisone
2
2019
221
0.170
Why?
Lymphoma
1
2023
233
0.170
Why?
Doxorubicin
2
2022
396
0.160
Why?
Lung Neoplasms
1
2014
2662
0.160
Why?
Adult
23
2023
40665
0.160
Why?
Translocation, Genetic
2
2013
119
0.160
Why?
Maintenance Chemotherapy
2
2017
42
0.150
Why?
Bacterial Infections
1
2022
246
0.150
Why?
Immunocompromised Host
1
2021
202
0.150
Why?
Diploidy
1
2019
16
0.150
Why?
Genes, p16
1
1999
13
0.150
Why?
Risk Factors
11
2022
10857
0.150
Why?
Hyperglycemia
1
2023
379
0.140
Why?
Chromosomes, Human, Pair 19
1
1998
27
0.140
Why?
Chromosomes, Human, Pair 17
1
1998
54
0.140
Why?
Quality of Life
3
2024
3194
0.140
Why?
Myelodysplastic Syndromes
1
2020
148
0.140
Why?
Antibodies, Bispecific
1
2019
68
0.140
Why?
Rituximab
1
2019
210
0.140
Why?
Chromosomes, Human, Pair 1
1
1998
80
0.140
Why?
Prospective Studies
9
2022
8035
0.140
Why?
Mutagenesis
1
1999
194
0.140
Why?
Prostate-Specific Antigen
2
2009
161
0.130
Why?
Substance Withdrawal Syndrome
1
2020
185
0.130
Why?
Proto-Oncogenes
1
1997
28
0.130
Why?
Patient Safety
1
2021
355
0.130
Why?
Family Relations
2
2016
87
0.130
Why?
Thioguanine
1
2017
18
0.130
Why?
Thionucleotides
1
2017
35
0.130
Why?
Apyrase
1
2017
27
0.130
Why?
Oncologists
1
2017
47
0.130
Why?
Blast Crisis
1
2016
34
0.120
Why?
Carboxypeptidases A
1
2016
2
0.120
Why?
Follow-Up Studies
6
2021
5411
0.120
Why?
Pediatricians
1
2017
121
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
267
0.120
Why?
Adrenal Cortex Hormones
1
2019
483
0.120
Why?
Osteonecrosis
1
2015
23
0.110
Why?
Sepsis
1
2022
662
0.110
Why?
Nausea
1
2016
112
0.110
Why?
Retrospective Studies
10
2023
17247
0.110
Why?
Mentors
2
2017
216
0.110
Why?
Depression
2
2016
1537
0.110
Why?
Cohort Studies
6
2026
5988
0.110
Why?
Pancreatitis
1
2016
146
0.110
Why?
Central Nervous System Neoplasms
1
2017
177
0.110
Why?
Dexamethasone
4
2021
365
0.110
Why?
Monitoring, Physiologic
1
2017
288
0.110
Why?
Mutation
4
2022
4071
0.110
Why?
Fusion Proteins, bcr-abl
2
2016
68
0.110
Why?
Longitudinal Studies
7
2016
2949
0.110
Why?
Mentoring
1
2017
165
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.110
Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
72
0.110
Why?
High-Throughput Nucleotide Sequencing
1
2017
530
0.100
Why?
Flow Cytometry
1
2018
1159
0.100
Why?
Bacteremia
1
2016
222
0.100
Why?
Repressor Proteins
1
1997
429
0.100
Why?
Cross Infection
1
2016
260
0.100
Why?
Antigens, CD
1
2017
558
0.100
Why?
Life Change Events
1
2014
145
0.100
Why?
Chromosomes, Human, Pair 21
1
2013
42
0.100
Why?
DNA-Binding Proteins
2
1998
1479
0.100
Why?
Histone-Lysine N-Methyltransferase
2
2010
141
0.100
Why?
Pediatrics
3
2021
1121
0.100
Why?
Immunotherapy
1
2018
665
0.090
Why?
Risk Assessment
5
2026
3740
0.090
Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.090
Why?
Venous Thromboembolism
1
2017
328
0.090
Why?
Transcription Factors
2
1998
1731
0.090
Why?
Myeloproliferative Disorders
1
2012
21
0.090
Why?
Karyotyping
3
2019
105
0.090
Why?
Self Report
1
2017
867
0.090
Why?
Quality Improvement
1
2021
1293
0.090
Why?
Contraindications
1
2012
90
0.090
Why?
Arabinonucleosides
1
2011
8
0.090
Why?
Adenine Nucleotides
1
2011
21
0.090
Why?
Prostatic Neoplasms
2
2009
978
0.080
Why?
Antibodies, Monoclonal
1
2018
1505
0.080
Why?
Chromosomes, Human, Pair 4
1
2010
25
0.080
Why?
Chromosomes, Human, Pair 10
1
2010
18
0.080
Why?
Pain
1
2016
781
0.080
Why?
Multivariate Analysis
4
2015
1546
0.080
Why?
T-Lymphocytes
1
2018
1993
0.080
Why?
Parents
2
2016
1401
0.070
Why?
Prostatectomy
1
2009
94
0.070
Why?
Age Factors
8
2019
3338
0.070
Why?
Bloom Syndrome
1
1988
3
0.070
Why?
Neoplasm Metastasis
1
2011
688
0.070
Why?
Juxtaglomerular Apparatus
1
2007
2
0.070
Why?
Gene Expression Regulation, Leukemic
2
2016
56
0.070
Why?
Polymerase Chain Reaction
1
2010
1039
0.060
Why?
Drug Administration Schedule
2
2017
781
0.060
Why?
Blood Coagulation
1
2008
274
0.060
Why?
Clinical Trials, Phase III as Topic
1
2026
116
0.060
Why?
Stress, Psychological
1
2014
1145
0.060
Why?
Clinical Trials as Topic
2
2024
1058
0.060
Why?
Surveys and Questionnaires
4
2024
6055
0.060
Why?
Animals
3
2024
37952
0.060
Why?
Methotrexate
2
2017
233
0.060
Why?
Remission Induction
2
2019
306
0.050
Why?
Case-Control Studies
3
2024
3616
0.050
Why?
Acute Disease
2
2019
1035
0.050
Why?
Selection Bias
1
2024
38
0.050
Why?
Personal Satisfaction
2
2017
218
0.050
Why?
Genetic Variation
1
1988
967
0.050
Why?
Incidence
3
2019
2915
0.050
Why?
Administration, Oral
2
2017
862
0.050
Why?
Kidney Neoplasms
1
2007
412
0.050
Why?
Risk
5
2023
916
0.050
Why?
Drug Monitoring
2
2017
399
0.050
Why?
Disease Progression
2
2021
2857
0.040
Why?
Proto-Oncogene Proteins c-cbl
1
2022
13
0.040
Why?
Randomized Controlled Trials as Topic
2
2020
1742
0.040
Why?
Exome
1
2022
227
0.040
Why?
Transcriptome
2
2019
1029
0.040
Why?
Menorrhagia
1
2001
22
0.040
Why?
Drug Therapy
1
2021
84
0.040
Why?
Diarrhea
2
1999
193
0.040
Why?
Bone Marrow
1
2022
306
0.040
Why?
Endocrine Glands
1
1979
14
0.040
Why?
Blood Cell Count
1
1999
55
0.040
Why?
Chromosomes, Human
1
2019
42
0.040
Why?
Genome-Wide Association Study
2
2016
1376
0.040
Why?
Cytogenetic Analysis
1
2019
33
0.040
Why?
Azacitidine
1
2020
157
0.040
Why?
Loss of Heterozygosity
1
1999
52
0.040
Why?
Viral Load
1
2021
525
0.040
Why?
Mosaicism
1
2019
73
0.040
Why?
Sequence Deletion
1
1999
190
0.040
Why?
Hypertension
1
2007
1269
0.030
Why?
Disinfectants
1
1999
45
0.030
Why?
National Cancer Institute (U.S.)
1
2018
54
0.030
Why?
Chromosomes
1
2019
106
0.030
Why?
Escherichia coli O157
1
1998
14
0.030
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
280
0.030
Why?
Infant, Newborn
4
2019
6435
0.030
Why?
Methylation
1
1998
242
0.030
Why?
Overweight
1
2023
609
0.030
Why?
Community Participation
1
1999
123
0.030
Why?
Biopsy
1
2021
1079
0.030
Why?
Genetic Predisposition to Disease
2
2017
2351
0.030
Why?
Interviews as Topic
1
2021
907
0.030
Why?
Erythrocyte Count
1
2017
21
0.030
Why?
United States
4
2021
16065
0.030
Why?
Glucose
1
2023
1048
0.030
Why?
Public Health Surveillance
1
2017
83
0.030
Why?
Escherichia coli Infections
1
1998
125
0.030
Why?
Food-Drug Interactions
1
2017
11
0.030
Why?
Proto-Oncogene Proteins c-ets
1
1997
56
0.030
Why?
Career Mobility
1
2017
68
0.030
Why?
Injections, Intramuscular
1
2017
146
0.030
Why?
Leucovorin
1
2017
98
0.030
Why?
Dairy Products
1
2017
30
0.030
Why?
Cerebrospinal Fluid
1
2017
88
0.030
Why?
MEF2 Transcription Factors
1
2016
51
0.030
Why?
Water Purification
1
1999
155
0.030
Why?
Cranial Irradiation
1
2017
85
0.030
Why?
Family
1
2021
682
0.030
Why?
Leukocyte Count
1
2017
316
0.030
Why?
Infusions, Intravenous
1
2017
428
0.030
Why?
Luciferases
1
2016
152
0.030
Why?
NIH 3T3 Cells
1
2016
146
0.030
Why?
Methyltransferases
1
2017
75
0.030
Why?
Feasibility Studies
1
2021
1109
0.030
Why?
Sulfonamides
1
2020
583
0.030
Why?
Ethers
1
1996
19
0.030
Why?
Methyl Ethers
1
1996
19
0.030
Why?
Bone Morphogenetic Protein 7
1
2015
12
0.030
Why?
Fluorides
1
1996
49
0.030
Why?
Cytarabine
1
2016
66
0.030
Why?
Hemorrhage
1
2001
822
0.030
Why?
Health Education
1
1999
345
0.030
Why?
Genotype
3
2017
1844
0.030
Why?
Anesthetics, Inhalation
1
1996
52
0.030
Why?
Breast Neoplasms
5
1979
2380
0.030
Why?
Severity of Illness Index
2
2017
2928
0.030
Why?
Spinal Dysraphism
1
1996
110
0.030
Why?
Histone Deacetylase Inhibitors
1
2016
218
0.030
Why?
Disease Management
1
2019
651
0.030
Why?
Middle Aged
10
2019
36126
0.030
Why?
Alternative Splicing
1
2017
247
0.030
Why?
Homeodomain Proteins
1
1998
522
0.030
Why?
HEK293 Cells
1
2017
740
0.030
Why?
Promoter Regions, Genetic
1
1999
1244
0.030
Why?
Sequence Analysis, RNA
1
2016
442
0.030
Why?
Intensive Care Units, Pediatric
1
2016
288
0.030
Why?
DNA Methylation
1
1999
667
0.030
Why?
Qualitative Research
1
2021
1671
0.020
Why?
Behavior
1
2014
89
0.020
Why?
Psychomotor Agitation
1
2014
69
0.020
Why?
Demography
1
2014
282
0.020
Why?
Income
1
2014
201
0.020
Why?
Marriage
1
2014
121
0.020
Why?
Algorithms
1
2021
1845
0.020
Why?
Base Sequence
1
2016
2168
0.020
Why?
Aged
9
2019
26096
0.020
Why?
Blood Glucose
1
2023
2335
0.020
Why?
Odds Ratio
1
2015
1082
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
323
0.020
Why?
Aggression
1
2014
178
0.020
Why?
Prevalence
2
2016
2855
0.020
Why?
Nucleoside Transport Proteins
1
2011
8
0.020
Why?
Kidney
2
1996
1494
0.020
Why?
Regression Analysis
1
2014
998
0.020
Why?
Time Factors
2
2015
7107
0.020
Why?
Antineoplastic Agents, Alkylating
1
2011
72
0.020
Why?
Escherichia coli
1
2015
834
0.020
Why?
Erythrocytes
1
2017
747
0.020
Why?
Bacteria
1
2016
765
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2011
178
0.020
Why?
Mice
2
2019
18303
0.020
Why?
Survival Analysis
1
2013
1371
0.020
Why?
Logistic Models
1
2015
2133
0.020
Why?
Obesity
1
2023
3097
0.020
Why?
Kaplan-Meier Estimate
1
2011
968
0.020
Why?
Sister Chromatid Exchange
1
1988
4
0.020
Why?
Cell Fusion
1
1988
48
0.020
Why?
Genetic Complementation Test
1
1988
72
0.020
Why?
Emotions
1
2014
573
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2008
85
0.020
Why?
Protein C
1
2008
54
0.020
Why?
Water Microbiology
2
1999
84
0.020
Why?
Antithrombins
1
2008
71
0.020
Why?
Mice, Inbred C57BL
1
2019
5972
0.020
Why?
Genetic Markers
1
1988
333
0.020
Why?
Fibrinogen
1
2008
180
0.020
Why?
Renin-Angiotensin System
1
2007
80
0.020
Why?
Transplantation, Homologous
1
2008
417
0.020
Why?
Biopsy, Needle
1
2007
185
0.020
Why?
Rare Diseases
1
2007
116
0.020
Why?
Blood Pressure Determination
1
2007
145
0.020
Why?
Nephrectomy
1
2007
161
0.010
Why?
Biomarkers
1
2017
4282
0.010
Why?
RNA, Messenger
1
2011
2803
0.010
Why?
Immunohistochemistry
1
2007
1713
0.010
Why?
Cell Line
1
1988
2821
0.010
Why?
Anemia, Hypochromic
1
2001
2
0.010
Why?
Blood Platelet Disorders
1
2001
10
0.010
Why?
von Willebrand Diseases
1
2001
28
0.010
Why?
Estriol
1
1979
6
0.010
Why?
Estrone
1
1979
41
0.010
Why?
Menstruation
1
1979
40
0.010
Why?
Prolactin
1
1979
87
0.010
Why?
Thrombocytopenia
1
2001
204
0.010
Why?
Bolivia
1
1999
63
0.010
Why?
Luteinizing Hormone
1
1979
206
0.010
Why?
Progesterone
1
1979
214
0.010
Why?
Food Handling
1
1998
33
0.010
Why?
Restaurants
1
1998
22
0.010
Why?
Follicle Stimulating Hormone
1
1979
262
0.010
Why?
Swimming
1
1998
54
0.010
Why?
Disease Transmission, Infectious
1
1998
69
0.010
Why?
Meat
1
1998
64
0.010
Why?
Water Supply
1
1998
89
0.010
Why?
Kyphosis
1
1996
37
0.010
Why?
Halothane
1
1996
8
0.010
Why?
Analysis of Variance
1
1999
1300
0.010
Why?
Estradiol
1
1979
512
0.010
Why?
Congenital Abnormalities
1
1996
109
0.010
Why?
Population Surveillance
1
1999
484
0.010
Why?
Feces
1
1998
494
0.010
Why?
Diagnostic Imaging
1
1996
337
0.010
Why?
Ovarian Neoplasms
1
1978
594
0.010
Why?
Pedigree
3
1978
515
0.010
Why?
Nebraska
2
1976
21
0.000
Why?
Aged, 80 and over
1
1999
8318
0.000
Why?
New York
2
1976
128
0.000
Why?
Genes
1
1978
226
0.000
Why?
Genetic Linkage
1
1978
271
0.000
Why?
Oncogenic Viruses
1
1976
3
0.000
Why?
Apocrine Glands
1
1976
4
0.000
Why?
Genetic Techniques
1
1976
66
0.000
Why?
Pheochromocytoma
1
1976
67
0.000
Why?
Statistics as Topic
1
1976
283
0.000
Why?
Syndrome
1
1976
380
0.000
Why?
Klinefelter Syndrome
1
1976
69
0.000
Why?
HLA Antigens
1
1976
238
0.000
Why?
Abnormalities, Multiple
1
1976
197
0.000
Why?
Skin Diseases
1
1976
152
0.000
Why?
Pregnancy
2
1978
7182
0.000
Why?
Sarcoma
1
1976
204
0.000
Why?
Sex Factors
1
1978
2099
0.000
Why?
Thyroid Neoplasms
1
1976
350
0.000
Why?
Neoplasms
2
1976
2900
0.000
Why?
Melanoma
1
1976
759
0.000
Why?
Phenotype
1
1976
3138
0.000
Why?
Registries
1
1976
2401
0.000
Why?
Brain Neoplasms
1
1976
1328
0.000
Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)